[Transport in blood and mode of action of a hypolipodemic agent related to clofibrate: G P 45.699. Presence in low density serum lipoproteins].
D000328:Adult; D001059:Apoproteins / Q000378:metabolism; D001692:Biological Transport; D001713:Biphenyl Compounds / Q000097:blood* / Q000494:pharmacology; D002784:Cholesterol / Q000378:metabolism; D002994:Clofibrate; D004987:Ethers / Q000097:blood / Q000494:pharmacology; D005227:Fatty Acids / Q000097:blood* / Q000494:pharmacology; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000097:blood* / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism; D013329:Structure-Activity Relationship; D013997:Time Factors; D014280:Triglycerides / Q000378:metabolism
D001059:Apoproteins; D001713:Biphenyl Compounds; D004987:Ethers; D005227:Fatty Acids; D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL; D012709:Serum Albumin; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate
Transport sanguin et mode d'action d'un médicament hypolipidémiant apparenté au clofibrate: le G P 45.699. Sa présence dans les lipoprotéines légères du sérum.